InsiderClue
← All stocks

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV Net selling
CIK 0001801170 #1978 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$6.79M
$5.74M on a plan · $0.00 straight out of an exercise
Sold at will
$1.06M
4 of 33 sales
Net
−$6.79M
−$1.06M against sales at will

By person

16 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Wai Conrad
CEO, Counterpart Health
—
$2.41M (3) scheduled
−$2.41M
3,625,811
0.692%
$17.11M
−17.9%
Toy Andrew
Chief Executive Officer
—
$2.37M (3) scheduled
−$2.37M
9,459,316
1.8%
$44.65M
−6.4%
Priest Brady Patrick
CEO of Clover Care Services
—
$724.85K (2)
−$724.85K
2,040,222
0.389%
$9.63M
−3.5%
Reynoso Jamie L.
CEO, Medicare Advantage
—
$462.64K (16) scheduled
−$462.64K
2,805,367
0.535%
$13.24M
+9.0%
Soares Karen
Chief Legal Officer
—
$336.59K (4) scheduled
−$336.59K
1,607,371
0.307%
$7.59M
+21.2%
Edwards Carladenise Armbrister
Director
—
$229.69K (1)
−$229.69K
285,432
0.054%
$1.35M
−30.8%
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
—
$162.02K (2)
−$162.02K
279,067
0.053%
$1.32M
−10.3%
THORNTON JOSEPH CLAY
Interim CFO
—
$99.65K (2) scheduled
−$99.65K
1,249,526
0.238%
$5.90M
+0.9%
Kuipers Peter J.
Chief Financial Officer
—
—
—
5,758,353
1.1%
$27.18M
−15.9%
Garipalli Vivek
Director
—
—
—
1,856,247
0.354%
$8.76M
+31.7%
Kouzoukas Demetrios L.
Director
—
—
—
605,980
0.116%
$2.86M
+30.1%
Clinton Chelsea
Director
—
—
—
602,814
0.115%
$2.85M
+11.3%
SHAPIRO LEE
Director
—
—
—
598,622
0.114%
$2.83M
+11.3%
Robinson William G Jr
Director
—
—
—
597,987
0.114%
$2.82M
+30.7%
Loengard Anna U
Director
—
—
—
557,066
0.106%
$2.63M
+42.8%
Tran Thomas L
Director
—
—
—
180,029
0.034%
$849.74K
+353.6%

Individual transactions

29
Insider
Date
Role
Action
Shares
Price
Amount
Wai Conrad
15 Sep 2026
CEO, Counterpart Health
Sold on a plan indirect
300,000
$4.72
$1.42M
Reynoso Jamie L.
15 Sep 2026
CEO, Medicare Advantage
Sold on a plan
9,273
$4.78
$44.32K
Soares Karen
15 Sep 2026
Chief Legal Officer
Sold on a plan
6,846
$4.78
$32.72K
THORNTON JOSEPH CLAY
17 Aug 2026
Interim CFO
Sold on a plan
17,775
$4.39
$78.03K
Toy Andrew
10 Aug 2026
Chief Executive Officer
Sold on a plan
87,798
$4.65
$408.26K
Soares Karen
20 Jul 2026
Chief Legal Officer
Sold on a plan
51,700
$4.51
$233.17K
Reynoso Jamie L.
17 Jul 2026
CEO, Medicare Advantage
Sold on a plan
4,839
$4.53
$21.92K
THORNTON JOSEPH CLAY
15 Jul 2026
Interim CFO
Sold on a plan
4,630
$4.67
$21.62K
Soares Karen
15 Jul 2026
Chief Legal Officer
Sold on a plan
10,519
$4.67
$49.12K
Reynoso Jamie L.
15 Jul 2026
CEO, Medicare Advantage
Sold on a plan
13,119
$4.67
$61.27K
Wai Conrad
15 Jul 2026
CEO, Counterpart Health
Sold on a plan
24,215
$4.67
$113.08K
Toy Andrew
15 Jul 2026
Chief Executive Officer
Sold on a plan
62,711
$4.67
$292.86K
Reynoso Jamie L.
8 Jul 2026
CEO, Medicare Advantage
Sold on a plan
2,384
$4.68
$11.16K
Reynoso Jamie L.
6 Jul 2026
CEO, Medicare Advantage
Sold on a plan
6,229
$5.26
$32.76K
Toy Andrew
1 Jul 2026
Chief Executive Officer
Sold on a plan
313,476
$5.32
$1.67M
Reynoso Jamie L.
17 Jun 2026
CEO, Medicare Advantage
Sold on a plan
2,360
$4.78
$11.28K
OLDAKOWSKI JOSEPH FRANK
16 Jun 2026
VP OF FINANCE AND CONTROLLER
Sold on a plan
12,102
$4.86
$58.82K
Reynoso Jamie L.
15 Jun 2026
CEO, Medicare Advantage
Sold on a plan
6,350
$4.61
$29.27K
Soares Karen
15 Jun 2026
Chief Legal Officer
Sold on a plan
4,681
$4.61
$21.58K
Reynoso Jamie L.
11 Jun 2026
CEO, Medicare Advantage
Sold on a plan
7,289
$4.91
$35.79K
Wai Conrad
28 May 2026
CEO, Counterpart Health
Sold on a plan indirect
220,426
$3.99
$879.50K
Reynoso Jamie L.
18 Mar 2026
CEO, Medicare Advantage
Sold on a plan
5,833
$1.91
$11.14K
Reynoso Jamie L.
20 Jan 2026
CEO, Medicare Advantage
Sold on a plan
4,597
$2.58
$11.86K
Reynoso Jamie L.
7 Jan 2026
CEO, Medicare Advantage
Sold on a plan
2,102
$2.53
$5.32K
Reynoso Jamie L.
18 Dec 2025
CEO, Medicare Advantage
Sold on a plan
4,913
$2.61
$12.82K
Reynoso Jamie L.
4 Nov 2025
CEO, Medicare Advantage
Sold on a plan
30,385
$3.58
$108.78K
Reynoso Jamie L.
17 Oct 2025
CEO, Medicare Advantage
Sold on a plan
16,514
$2.69
$44.42K
Reynoso Jamie L.
7 Oct 2025
CEO, Medicare Advantage
Sold on a plan
2,012
$2.65
$5.33K
Reynoso Jamie L.
17 Sep 2025
CEO, Medicare Advantage
Sold on a plan
4,914
$3.09
$15.18K
Show all 33 transactions →

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 9,108,606
History held since 11 Jan 2021